Albograft Surgical Graft Recall Issued After Bleeding Incident

A vascular graft that is used to seal damaged arteries has been recalled, due to a potential risk that it may cause serious injury or death.

The Albograft Vascular Graft recall was posted by the FDA on Wednesday, and has been designated as a class I medical device recall, suggesting that the federal regulatory agency believes that continued use of the device poses a substantial risk for patients.

The manufacturer, LeMaitre Vascular, Inc. of Burlington, Massachusetts, sent an Urgent Field Safety Notice out to customers on June 19, warning that reports suggest blood may leak through the surface of the grafts after implantation. The Albograft is a synthetic graft used to repair or replace arteries damaged by an aneurysm or blockage caused by disease.

Did You Know? Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

The recall affects Albograft Vascular Grafts manufactured in April 2011 and distributed between April 2011 and June 2013. The recall affects batch 56890A and model numbers AMC1408, AMC1506, AMC1608, AMC1809, AMC1810, AMC2010, AMC4007, AMC4008, AMC6006, AMC6007, AMC6008, ATC1526, ATC1530, ATC3016, ATC3018, ATC3024, and ATC3026.

The Class I medical device recall designation is the most serious classification of recall the FDA can declare. It means that the agency believes that there is a reasonable probability that the recalled product will cause severe injury or death. However, there have been no reported injuries or deaths to date.

The manufacturer has instructed customers to identify and return the affected grafts to LeMaitre Vascular, which will replace them with other grafts. The company has also visited customers and had its representatives remove the devices.

Customers with questions can call LeMaitre Vascular at 781-221-2266, extension 183. The FDA requests that health care professionals and consumers who experience an adverse event related to this device report such incidents to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

Image Credit: |

0 Comments

"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

LifeCell Hernia Mesh Lawsuit Filed After Strattice Tissue Matrix Failed
LifeCell Hernia Mesh Lawsuit Filed After Strattice Tissue Matrix Failed (Posted 3 days ago)

LifeCell faces a hernia mesh lawsuit after one of its Strattic Tissue Matrix mesh products failed in a South Carolina woman just a year after being implanted, requiring revision surgery.